Pharmacists in Webster, WI Accepting Medicare
7 Pharmacists found. Showing 1 - 7
 James C Olson Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 7438 Main St W, Webster, WI 54893 Phone: 715-866-8644 Fax: 715-866-7344 |
 Dr. Erica Kristen Paffel, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 7438 Main St W, Webster, WI 54893 Phone: 715-866-8644 Fax: 715-866-7344 |
Mr. David Edward Detienne, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 4404 State Road 70, Webster, WI 54893 Phone: 715-349-8554 |
Kiah Weseli, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 7438 Main St W, Webster, WI 54893 Phone: 715-866-8644 |
Mrs. Tiffany Marie Herring, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 7438 Main St W, Webster, WI 54893 Phone: 715-866-8644 Fax: 715-866-7344 |
Amber Heinz, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 7438 Main St W, Webster, WI 54893 Phone: 715-866-8644 |
Dr. Emily Jane Zajac, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 7438 Main St W, Webster, WI 54893 Phone: 715-866-8644 Fax: 715-866-7344 |
News Archive
USPTO grants key patent for Quark Pharmaceuticals' QPI-1007 ocular neuroprotectant
Quark Pharmaceuticals, Inc. today announced that the United States Patent and Trademark Office has granted a key patent covering the treatment of patients suffering from non-arteritic anterior ischemic optic neuropathy ("NAION") with the Company's ocular neuroprotectant QPI-1007.
Caltech biologists gain new insight into migrating cells
At any given moment, millions of cells are on the move in the human body, typically on their way to aid in immune response, make repairs, or provide some other benefit to the structures around them. When the migration process goes wrong, however, the results can include tumor formation and metastatic cancer. Little has been known about how cell migration actually works, but now, with the help of some tiny worms, researchers at the California Institute of Technology (Caltech) have gained new insight into this highly complex task.
Activating rearrangements in receptor genes are more common than previously thought
A multi-institutional team led by investigators from Memorial Sloan-Kettering Cancer Center has published a study that provides new insight into genetic changes that make some forms of glioblastoma, the most common type of primary brain cancer, more aggressive than others and explains why they may not respond to certain therapies. The research was led by senior author Eric C. Holland, MD, PhD,-an MSKCC surgeon, researcher and the Director of the Brain Tumor Center-and was published in the October 1 issue of the journal Genes & Development.
Comprehensive smokefree laws considered as victory for public health and parliament
Comprehensive smokefree laws including pubs and bars came into force ten years ago. They are rightly considered a victory for public health and a model of good regulation. But they would not have come into effect without strong cross-party support from parliament.
Dust-up continues over Obama administration's contraception rule
Although administration officials defend the rule and some political strategists see limited political damage, the Catholic Church continues a counterattack.
› Verified 7 days ago